Tomer Gold

Direttore Tecnico/Scientifico/R&S presso Dexcel Pharma Technologies Ltd.

52 anni

Health Technology

Consumer Services

Posizioni attive di Tomer Gold

Società	Posizione	Inizio	Fine
Dexcel Pharma Technologies Ltd. Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel.	Direttore Tecnico/Scientifico/R&S	01/01/2011	-

Società	Posizione	Inizio	Fine
CYNAPSUS THERAPEUTICS INC	Direttore/Membro del Consiglio	09/05/2013	21/10/2016
CYNAPSUS THERAPEUTICS INC	Independent Dir/Board Member	04/08/2014	21/10/2016

Technion-Israel Institute of Technology

Graduate Degree

Distribuzione geografica

Israele	3
Canada	2

Posizioni

Director/Board Member	1
Independent Dir/Board Member	1
Graduate Degree	1

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	2
Cynapsus Therapeutics, Inc. Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cynapsus Therapeutics, Inc. operated as a pharmaceutical company, which developed an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease. The company was founded by Andrew Williams and David Hill on January 16, 2004 and was headquartered in Toronto, Canada.	Health Technology
Dexcel Pharma Technologies Ltd. Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel.	Health Technology